Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs; notice.
D000367:Age Factors; D015507:Drugs, Investigational; D035082:Federal Government; D005260:Female; D006076:Government; D033161:Government Regulation; D017408:Guidelines as Topic; D006805:Human Experimentation; D006801:Humans; D008571:Men; D018579:Patient Selection; D004364:Pharmaceutical Preparations; D011247:Pregnancy; D037841:Pregnant People; D011619:Psychotropic Drugs; D011640:Public Policy; D012107:Research Design; D035842:Research Subjects; D012926:Social Control, Formal; D013223:Statistics as Topic; D014481:United States; D014486:United States Food and Drug Administration; D014930:Women; D016387:Women's Health
Biomedical and Behavioral Research; General Accounting Office; Legal Approach